Further studies are now indicated in biospecimens of patients at high risk for CC, such as those with PSC, to assess the value of BMP3 and other methylation markers for screening or early detection of CC in biospecimens such as bile, bile duct brushings, blood or stool. The gene discussed is BMP3; the disease is cholangiocarcinoma.